Margitte C. Retz
Kuno Fischer Str. 8
Berlin, BE 14057, Germany
Berlin, BE 14057, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Pembrolizumab plus enzalutamide and androgen deprivation therapy versus placebo plus enzalutamide and androgen deprivation therapy for metastatic hormone-sensitive prostate cancer: the randomized, double-blind, phase III KEYNOTE-991 study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 23, 2025
Pembrolizumab plus enzalutamide versus placebo plus enzalutamide for chemotherapy-naive metastatic castration-resistant prostate cancer: the randomized, double-blind, phase III KEYNOTE-641 study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 23, 2025
Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 17, 2025
German expert consensus on programmed cell death ligand 1 (PD-L1) testing in perioperative systemic therapy of muscle invasive bladder cancer
Journal: Urologie (Heidelberg, Germany)
Published: July 15, 2024
Value of immunotherapy in the perioperative treatment of localized muscle invasive bladder cancer
Journal: Urologie (Heidelberg, Germany)
Published: October 17, 2022
"Surgery only" is not enough: potential of multimodal therapy in urothelial bladder carcinoma
Journal: Urologie (Heidelberg, Germany)
Published: October 05, 2022
Quality assurance for the treatment of muscle-invasive and metastasized bladder carcinoma in Germany : An initiative of the Working Groups Urological Oncology (AUO) and Internal Oncology (AIO) in the German Cancer Society (DKG)
Journal: Urologie (Heidelberg, Germany)
Published: May 15, 2022
EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 20, 2019
Last Updated: 09/26/2026